Clinical Trial Update: Avatrombopag vs. Placebo for CIT in GI Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing avatrombopag to placebo for chemotherapy-induced thrombocytopenia in gastrointestinal cancers; the study is currently not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Gastrointestinal Cancer
• Gastrointestinal Neoplasms

Drugs mentioned

• DOPTELET (avatrombopag)

Snippet

Sponsor: Hanny Al-Samkari, MD | Conditions: Gastrointestinal Cancer, Gastrointestinal Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING